Jin Y - Search Results

1

Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.

Cao Y, Jin Y, Yu J, Wang J, Qiu Y, Duan X, Ye Y, Cheng Y, Dong L, Feng X, Wang D, Li Z, Tian X, Wang H, Yan J, Zhao Q. Cao Y, et al. Among authors: jin y. Oncotarget. 2017 Jul 25;8(30):49689-49701. doi: 10.18632/oncotarget.17917. Oncotarget. 2017. PMID: 28591696 Free PMC article.

2

Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.

Ma ZL, Zhang BJ, Wang DT, Li X, Wei JL, Zhao BT, Jin Y, Li YL, Jin YX. Ma ZL, et al. Among authors: jin yx, jin y. Oncotarget. 2015 Aug 21;6(24):20111-20. doi: 10.18632/oncotarget.3933. Oncotarget. 2015. PMID: 26036635 Free PMC article.

3

Research progress of neuroblastoma related gene variations.

Cao Y, Jin Y, Yu J, Wang J, Yan J, Zhao Q. Cao Y, et al. Among authors: jin y. Oncotarget. 2017 Mar 14;8(11):18444-18455. doi: 10.18632/oncotarget.14408. Oncotarget. 2017. PMID: 28055978 Free PMC article. Review.

4

A single center clinical analysis of children with high-risk neuroblastoma.

Tian X, Cao Y, Wang J, Yan J, Tian Y, Li Z, Wang H, Duan X, Jin Y, Zhao Q. Tian X, et al. Among authors: jin y. Oncotarget. 2017 May 2;8(18):30357-30368. doi: 10.18632/oncotarget.15996. Oncotarget. 2017. PMID: 28423674 Free PMC article.

5

Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome.

Zhu FY, Yan J, Cao YN, Jin Y, Li J, Zhao Q. Zhu FY, et al. Among authors: jin y. Pediatr Hematol Oncol. 2021 Sep;38(6):543-554. doi: 10.1080/08880018.2021.1894277. Epub 2021 Jun 9. Pediatr Hematol Oncol. 2021. PMID: 34106032 Clinical Trial.

6

The application and value of radiotherapy at the primary site in patients with high-risk neuroblastoma.

Wei Z, Li J, Jin Y, Liu Y, Wang P, Cao Y, Zhao Q. Wei Z, et al. Among authors: jin y. Br J Radiol. 2022 Jun 1;95(1134):20211086. doi: 10.1259/bjr.20211086. Epub 2022 Mar 23. Br J Radiol. 2022. PMID: 35312349 Free PMC article.

7

Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.

Ma J, Jin Y, Gong B, Li L, Zhao Q. Ma J, et al. Among authors: jin y. Discov Oncol. 2022 Mar 21;13(1):17. doi: 10.1007/s12672-022-00477-2. Discov Oncol. 2022. PMID: 35312867 Free PMC article.

8

B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met/AKT/mTOR/IRF-1 axis in neuroblastoma.

Sha YL, Liu Y, Yang JX, Wang YY, Gong BC, Jin Y, Qu TY, Xia FT, Han L, Zhao Q. Sha YL, et al. Among authors: jin y. J Exp Clin Cancer Res. 2022 Oct 25;41(1):314. doi: 10.1186/s13046-022-02523-x. J Exp Clin Cancer Res. 2022. PMID: 36284313 Free PMC article.

9

Comprehensive quantifications of tumour microenvironment to predict the responsiveness to immunotherapy and prognosis for paediatric neuroblastomas.

Song M, Sun Y, Hu Y, Wang C, Jin Y, Liu Y, Da Y, Zhao Q, Zheng R, Li L. Song M, et al. Among authors: jin y. Int Immunopharmacol. 2024 May 30;133:112145. doi: 10.1016/j.intimp.2024.112145. Epub 2024 Apr 30. Int Immunopharmacol. 2024. PMID: 38691920

10

Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer.

Fu F, Deng C, Sun W, Zheng Q, Jin Y, Li Y, Zhang Y, Chen H. Fu F, et al. Among authors: jin y. Respir Res. 2022 Nov 5;23(1):302. doi: 10.1186/s12931-022-02201-8. Respir Res. 2022. PMID: 36335353 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,713 results

Search Page

Filters